
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 17, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial".
Filed with NSE · · 3 pages · English

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 17, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial".
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals